Skip to main content

Bank Of America Corp's Form 4 filing

ENvue Medical, Inc. (FEED) · filed Feb 4, 2026

Accession no.
0000070858-26-000030
Filed
Feb 4, 2026, 9:03 PM ET
Trade date
Feb 2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 30 non-derivative transactions. Open-market sales total $8.91K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bank Of America CorpCIK 000007085810% Owner
Bank Of America NACIK 000110211310% Owner
Bofa Securities, Inc.CIK 000167536510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2026Common StockSSaleDisposed−100$3.05−$305233,956Indirect
Feb 2, 2026Common StockSSaleDisposed−10$3.05−$30.5233,946Indirect
Feb 2, 2026Common StockSSaleDisposed−4$3.05−$12.2233,942Indirect
Feb 2, 2026Common StockSSaleDisposed−4$3.05−$12.2233,938Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.04−$304233,838Indirect
Feb 2, 2026Common StockSSaleDisposed−200$3.06−$612233,638Indirect
Feb 2, 2026Common StockSSaleDisposed−500$3.05−$1,525233,138Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5233,088Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5233,038Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5232,988Indirect
Feb 2, 2026Common StockSSaleDisposed−18$3.05−$54.9232,970Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5232,920Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.05−$305232,820Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5232,770Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.05−$305232,670Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.05−$305232,570Indirect
Feb 2, 2026Common StockSSaleDisposed−183$3.05−$558.15232,387Indirect
Feb 2, 2026Common StockSSaleDisposed−2$3.05−$6.1232,385Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5232,335Indirect
Feb 2, 2026Common StockSSaleDisposed−417$3.05−$1,271.85231,918Indirect
Feb 2, 2026Common StockSSaleDisposed−98$3.05−$298.9231,820Indirect
Feb 2, 2026Common StockSSaleDisposed−82$3.05−$250.1231,738Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5231,688Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.06−$306231,588Indirect
Feb 2, 2026Common StockSSaleDisposed−50$3.05−$152.5231,538Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.07−$307231,438Indirect
Feb 2, 2026Common StockSSaleDisposed−90$3.05−$274.5231,348Indirect
Feb 2, 2026Common StockSSaleDisposed−10$3.05−$30.5231,338Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.07−$307231,238Indirect
Feb 2, 2026Common StockSSaleDisposed−100$3.05−$305231,138Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Remaining trades included in attached schedule See Exhibit 99.2

Read the full filing on SEC EDGAR (opens in a new tab)